📅 2026 Update: Advances in Mesothelioma Treatment

Since the original article was published, there have been significant advancements in the treatment options for mesothelioma. New FDA approvals and updated guidelines could impact patient care and treatment choices. The earlier article continues further down the page, providing a comprehensive overview of mesothelioma, asbestos exposure, and claims.

🚀 FDA Approvals for New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) as a first-line treatment for unresectable advanced or metastatic pleural mesothelioma. This combination therapy with pemetrexed and platinum chemotherapy showed a median overall survival of 17.3 months. This is an improvement compared to the 16.1 months seen with chemotherapy alone.

💊 Opdivo® and Yervoy® Combination Approval

The FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) for inoperable malignant pleural mesothelioma in 2024. Results from the CheckMate 743 trial indicated a median overall survival of 18.1 months, compared to 14.1 months for those treated with chemotherapy alone.

🏥 Updated Surgical Guidelines

The National Comprehensive Cancer Network (NCCN) released new guidelines in 2026. They recommend pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now reserved for rare cases, and surgery is no longer recommended for stages 2 through 4 of pleural mesothelioma.

💰 Treatment Costs

As of October 2026, the average wholesale price for Keytruda® is about $10,000 per 100 mg vial. The costs for Opdivo® and Yervoy® are lower, with Opdivo® at around $7,000 per 100 mg vial and Yervoy® at approximately $1,200 per 50 mg vial. The overall cost of treatment will vary based on individual needs and insurance coverage.

📌 Key Takeaways

  • FDA approved Keytruda® and Opdivo®/Yervoy® for mesothelioma.
  • Median survival rates improved with new treatments.
  • NCCN guidelines favor P/D over EPP.
  • Treatment costs vary significantly based on individual factors.
  • Consult healthcare providers for the latest treatment options.

💡 Tips for Navigating Mesothelioma Treatment Options

Reviewing your specific situation with an attorney is essential for understanding your options.

🩺 Understand New Treatment Options

Keep informed about the latest advancements in mesothelioma treatments. New FDA-approved therapies like Keytruda® and the Opdivo®/Yervoy® combination offer new hope for patients.

📅 Explore Clinical Trials

Consider enrolling in clinical trials to access cutting-edge therapies. Clinical trials often provide opportunities for patients to receive new treatments before they are widely available.

🏥 Discuss Eligibility Criteria

Talk to your healthcare provider about eligibility for new treatments. Each patient’s health and cancer stage can affect access to certain therapies.

💰 Assess Treatment Costs

Be aware of the costs associated with new therapies. Understanding the expenses and potential insurance coverage can help in planning for treatment.

📞 Seek Nonprofit Support

Utilize resources from nonprofits like the Mesothelioma Applied Research Foundation. They offer valuable information on treatment options and clinical trials.

🏆 Free Options Ranked by User Reviews (2026)

No national paid services met the review threshold for this topic, so this section highlights free government and nonprofit resources that can support those affected by mesothelioma.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization offers extensive resources and support for mesothelioma patients. They provide information on treatment options and guidance for accessing clinical trials, helping patients make informed decisions about their care.

🥈 2. National Cancer Institute (NCI)

The NCI is a reliable source of information on mesothelioma, including treatment choices and clinical trials. Their website features detailed guides and contact information for patients seeking assistance and support.

🥉 3. Centers for Disease Control and Prevention (CDC)

The CDC offers information on asbestos exposure and its health effects. They provide resources to help individuals understand the risks associated with mesothelioma and how to seek help.

4️⃣ U.S. Department of Veterans Affairs (VA)

The VA provides benefits and support for veterans diagnosed with mesothelioma. They help eligible veterans access healthcare services and treatment options specifically tailored to their needs.

5️⃣ American Cancer Society (ACS)

The ACS offers resources, support, and information for cancer patients, including those with mesothelioma. They provide guidance on treatment options, coping strategies, and support groups.

🔎 What to Check Before Paying for Help

  • 🏢 Verify the organization's legitimacy.
  • 📊 Look for user reviews and testimonials.
  • 📞 Confirm available services and support options.
  • 📝 Understand any costs involved upfront.
  • 🤝 Check if they offer free resources.

❓ Frequently Asked Questions

❓ What are the latest treatment options for mesothelioma?

Recent FDA approvals include Keytruda® and the Opdivo®/Yervoy® combination, both showing improved survival rates over traditional chemotherapy.

📈 How do clinical trials work for mesothelioma treatments?

Clinical trials investigate new therapies and often require patients to meet specific eligibility criteria. Discussing options with healthcare providers can help find suitable trials.

🏥 What is the cost of newer mesothelioma treatments?

The average costs for Keytruda® and the Opdivo®/Yervoy® combination vary significantly, depending on dosage, frequency, and insurance coverage.

🏅 Are there any nonprofit organizations for mesothelioma support?

Yes, organizations like the Mesothelioma Applied Research Foundation and the National Cancer Institute provide valuable resources and support for patients and families.

📅 How do I find out about new clinical trials?

Consult your healthcare provider for information on ongoing clinical trials, as they can provide the latest updates and guidance on participation.

🏚️ What are the risks of asbestos exposure?

Asbestos exposure can lead to serious health issues, including mesothelioma. Understanding these risks is crucial for those who may have been exposed.

⚖️ Recent Cases Related to Mesothelioma Treatment

Recent court rulings have addressed various aspects of mesothelioma claims and treatment access. These rulings may influence patient rights and treatment options available to those affected by asbestos exposure.

For additional insights, explore more rulings on the news page.

End of October 2026 Update






 



What is Onconase? 



 

Onconase


 



Onconase is the trademark name given to Ranpirnase, a ribonuclease enzyme found in the Northern Leopard Frog. Onconase is currently being studied to combat peritoneal and pleural mesothelioma cancer. The chemotherapy drug is manufactured by Tamir Biotechnology Inc. headquartered in Monmouth Junction, NJ. Onconase is demonstrated as a selective cytotoxic against cancerous tumor cells and has thus, been used empirically to combat malignant mesothelioma cancer. Some mesothelioma patients, in the aforementioned clinical trials, have enjoyed a prolonged survival rate following the administration of Onconase. 



 



 



According to Tamir Biotechnology Inc, Onconase is a biopharmaceutical product candidate that works in a similar fashion to RNA interference. Onconase is an RNase that defeats the challenge of locating RNA for therapeutic reasons while, at the same time, enabling the creation of a new class of therapies for the treatment of viral, cancer and other life-challenging medical conditions. Currently, the company is conducting a Phase II clinical trial that uses Onconase in conjunction with PEMETREXED and Carboplatin for patients with non-small cell lung and/or non-squamous lung cancer. 



 



 



According to Tamir Biotechnology, Onconase is a first-in-class chemotherapy drug that utilizes proprietary ribonuclease technology. Onconase is created by isolating a natural protein produced naturally by the leopard frog; Onconase, according to laboratory and clinical trials, is shown to target cancerous cells while sparing healthy/normal ones. Onconase triggers apoptosis, the natural termination of cells, through multiple molecular mechanisms of a synthetic action. 



 



 



Onconase is a chemotherapy agent that is currently being tested for all mesothelioma patients. Like the bulk of mesothelioma chemotherapy drugs, Onconase reaches the cancer by specifically targeting rapidly-dividing cells. Once the drug is administered, Onconase binds to these tumors cells, ultimately inhibiting their growth and causing their death. Onconase stands out from other chemo drugs because it causes manageable side effects. 



 



 



Although Onconase is still in testing phases, the United States Food and Drug Administration recognizes the drug’s potential in mesothelioma treatment. The Food and Drug Administration granted Onconase an orphan drug classification to speed-up testing phases and give the drug the opportunity to be approved faster. Onconase is also regarded as a helpful candidate for the treatment of lung and breast cancer. 



 



 



How Does Onconase Work?



 



 



Onconase is administered through an IV each week for 30 minute intervals. The amount of weeks a patient receives varies depending on several factors, including the patient’s overall health, their initial response to the treatment and whether another chemotherapy drug is being administered. When Onconase adheres to the surface of cancerous cells, it is said to penetrate the cell’s protective membranes. Once the drug enters the cell, Onconase interferes with the messages and information within the cancerous cell, causing a significant interruption in its ability to process. This eventually leads to the termination of the cancerous cells, promoting the shrinking of cancerous tumors. 



 



 



Onconase is typically used in conjunction with other chemotherapy drugs or chemotherapy agents to improve its efficacy and potency. Onconase will cause minor side effects which are regarded as significantly more manageable than those caused by other chemotherapy practices. In most patients, Onconase will yield the following side effects: hair loss, nausea, fatigue and headaches. 



 



 



Is Onconase Effective in Battling Mesothelioma Cancer?



 



 



A 2003 Phase II clinical trial of Onconase served as an early test of the drug’s efficiency in combatting mesothelioma cancer. A team of researchers tested Onconase in 105 patients (39 of whom had previously undergone mesothelioma chemotherapy with no results). Each patient was given Onconase via an IV for 30 minutes each week. In general, researchers noticed a median survival rate between six and eight months. These survival rates are comparable to or better than a number of types of mesothelioma chemotherapy treatments, including cisplatin and doxorubicin. 



 



 



Following this test, researchers conducted a Phase III clinical trial of Onconase that involved 415 mesothelioma cancer patients. During this trial, one group of mesothelioma patients was given a combination of doxorubicin and Onconase, while the other group was given doxorubicin as a single medication. The results showed no significant difference—with regards to median survival—between the two groups. Patients receiving both mesothelioma treatment methods lived, on average, for 11 months, a minor improvement to the 10.7 months average that patients experienced while taking doxorubicin on its own. However, researchers noticed a significant improvement among 130 mesothelioma patients who had previously received chemotherapy without any results. Among these mesothelioma patients, adding Onconase to doxorubicin extended the patient’s life by an average of 1.5 months.